Breast cancer screening
What the major U.S. guidelines recommend, with a link to verify each at the source. A quick-reference summary for clinicians, not medical advice.
ACS · 2015
Annual 45–54; option to start 40–44; 55+ may switch to q1–2y; continue while healthy with ≥10y life expectancy.
Verify at ACS →ACOG · 2017
Offer starting at 40; begin by 50; q1–2y through ≥75 with shared decision-making.
Verify at ACOG →